M&A Deal Summary |
|
|---|---|
| Date | 2021-09-19 |
| Target | Embark Health |
| Sector | Consumer Products |
| Buyer(s) | BevCanna Enterprises |
| Deal Type | Add-on Acquisition |
| Deal Value | 21M USD |
SEARCH BY
Try For Free 7-Day Free Trial
BevCanna Enterprises, Inc. develops and manufactures cannabinoid–infused beverages and consumer products for in–house brands and white label clients. BevCanna Enterprises is based in Vancouver, Canada.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector (Consumer Products) | 1 of 1 |
| Type (Add-on Acquisition) | 3 of 3 |
| State (Ontario) | 1 of 1 |
| Country (Canada) | 3 of 3 |
| Year (2021) | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-11-24 |
Trace Beverages
Vancouver, British Columbia, Canada Trace Beverages develops and manufactures beverages and consumer products for in–house brands and white label clients. With decades of experience creating, branding, and distributing iconic brands that have resonated with consumers on a global scale. Trace Beverages owns and operates nationally distributed house brands across Canada which are currently sold in more than 3000 Canadian retailers, including 7/11, Loblaws, London Drugs, Metro, and Farm Boy, as well as online direct-to-consumers, via Amazon; and is expanding into the U.S. market in 2021. Based in British Columbia, Canada, Trace Beverages owns a pristine alkaline spring water aquifer, a world-class 40,000–square–foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 210M bottles per annum. |
Buy | - |
